You are here: All Products  > Qihan Starts Trial of Gene-Edited iPSC-Derived NK Cell Therapy for Leukemia

Qihan Starts Trial of Gene-Edited iPSC-Derived NK Cell Therapy for Leukemia

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products